Severe Acute Respiratory News and Research

RSS

Illustrating a rapid response approach for monkeypox management

Researchers illustrated a rapid response strategy for managing monkeypox outbreaks.

20 Jun 2022

Implications of impaired type I interferon immunity and increasing COVID-19 severity

Researchers demonstrated that impaired type I interferon immunity is associated with increasing coronavirus disease 2019 severity.

20 Jun 2022

The feasibility of sperm cryopreservation for male COVID-19 patients

In an article recently published in Frontiers in Endocrinology, scientists deciphered the possibility of cryopreserving sperm of coronavirus disease 2019 (COVID-19) patients

20 Jun 2022

Evaluating post-acute sequelae of COVID-19 using cardiopulmonary exercise testing

Researchers demonstrated reduced exercise capacity due to persistent cardiopulmonary symptoms among COVID-19 survivors hospitalized for acute infection and those having long COVID.

20 Jun 2022

SARS-CoV-2 spike circulating in most long COVID 12 months post-diagnosis

In a recent study posted to the medRxiv* preprint server, researchers explored the association between circulating coronavirus disease 2019 (COVID-19) antigens and post-COVID-19 sequelae (long COVID).

20 Jun 2022

Model predicts effectiveness of COVID-19 vaccines against circulating SARS-CoV-2 variants

In a recent study published in the journal Nature Medicine, researchers assessed the coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) against symptomatic infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and variants of interest (VOIs) by genetic mismatch/distance (GD) analysis.

20 Jun 2022

SARS-CoV-2 variants of concern exhibit divergent interactions with host proteases

In a recent study posted to the bioRxiv* preprint server, researchers at Weill Cornell Medical College assessed the cleavability of the spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and related coronaviruses by several proteases of the host.

19 Jun 2022

How effective are mRNA COVID-19 vaccine boosters against Omicron?

In a recent study posted to the medRxiv* preprint server, researchers University of Washington, University of Michigan, Duke University, and Veterans Affairs Portland Healthcare System assessed the effectiveness of the coronavirus disease 2019 (COVID-19) booster vaccines.

19 Jun 2022

Long-COVID risk reduced with Omicron versus Delta

In a recent study published in The Lancet, researchers at King's College London and ZOE Limited assessed the risk of long coronavirus disease (COVID) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants in the United Kingdom (UK).

19 Jun 2022

Effectiveness of previous COVID-19 and vaccination against SARS-CoV-2 Omicron infection

Researchers studied the effects of prior immunity on symptomatic infection by SARS-CoV-2 Omicron.

17 Jun 2022

Assessing neurological symptoms present in long COVID patients

Researchers assessed the symptoms of neurological post-acute sequelae of SARS-CoV-2 infection (neuro-PASC) among patients with and without neurologic disorders.

17 Jun 2022

Study explains the structural basis of higher ACE2 binding affinity of Omicron sub-variants

A team of scientists from China has recently deciphered the structural basis of comparatively higher binding affinity of two Omicron sub-variants, namely B.1.1 and B.2, for human angiotensin-converting enzyme 2 (ACE2).

17 Jun 2022

SARS-CoV-2 variant-specific polymerase chain reaction assay for SARS-CoV-2 genomic surveillance

Researchers reported on the misclassification of the SARS-CoV-2 Omicron BA.1 subvariant as Omicron BA.2 subvariant in an automated variant-specific polymerase chain reaction analysis.

17 Jun 2022

Researchers investigate COVID fog and chemokine C–C motif ligand 11

Researchers assessed the characteristics of the brain fog reported by some COVID-19 patients.

17 Jun 2022

Scientists explore effectiveness of neutralizing antibodies against SARS-CoV-2 Omicron variant

Researchers assessed the impact of SARS-CoV-2-neutralizing antibodies on the SARS-CoV-2 Omicron variant.

17 Jun 2022

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

In a recent study posted to the bioRxiv* pre-print server, researchers at Cornell University College of Veterinary Medicine and the University of Illinois Urbana-Champaign compared the infection dynamics, pathogenicity, and tissue tropism of multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in adult cats.

17 Jun 2022

GPR183 gene a novel drug target for severe COVID-19

In a recent study posted to the bioRxiv* pre-print server, researchers provide the first preclinical evidence of the usefulness of antagonists of G-protein coupled receptor 183 (GPR183), also known as Epstein-Barr virus-induced gene 2 (EBI2), in reducing coronavirus disease 2019 (COVID-19) severity.

17 Jun 2022

Severe Acute Respiratory News and Research

Illustrating a rapid response approach for monkeypox management

Implications of impaired type I interferon immunity and increasing COVID-19 severity

The feasibility of sperm cryopreservation for male COVID-19 patients

Evaluating post-acute sequelae of COVID-19 using cardiopulmonary exercise testing

SARS-CoV-2 spike circulating in most long COVID 12 months post-diagnosis

Model predicts effectiveness of COVID-19 vaccines against circulating SARS-CoV-2 variants

SARS-CoV-2 variants of concern exhibit divergent interactions with host proteases

How effective are mRNA COVID-19 vaccine boosters against Omicron?

Long-COVID risk reduced with Omicron versus Delta

Effectiveness of previous COVID-19 and vaccination against SARS-CoV-2 Omicron infection

Assessing neurological symptoms present in long COVID patients

Study explains the structural basis of higher ACE2 binding affinity of Omicron sub-variants

SARS-CoV-2 variant-specific polymerase chain reaction assay for SARS-CoV-2 genomic surveillance

Researchers investigate COVID fog and chemokine C–C motif ligand 11

Scientists explore effectiveness of neutralizing antibodies against SARS-CoV-2 Omicron variant

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

GPR183 gene a novel drug target for severe COVID-19

HIV coinfection significantly impacts B cell response to SARS-CoV-2

Novel luminescent biosensor detects SARS-CoV-2 spike protein using cell phone camera

Co-circulation of respiratory viruses during the SARS-CoV-2 Alpha surge

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News